Clinical Trial Update: Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update of eltrombopag with standard immunosuppression for severe aplastic anemia. The Phase 1/2 study had results posted in 2020 and was listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe Aplastic Anemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-06-05